Gotay CC. Trial related quality of life; using quality of life instrument to distinguish among cancer therapies. Monograph J Natl Cancer Inst 1996; 20: 1-6
Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer. A follow-up study 7 to 11 year after radiotherapy. Int J Radiat Oncol Biol Phys 1994: 28: 847-856.
Chawla S, Mohanti BK, Rakshak M, Saxena S, Rath GK, Bahadur S. Temporal assessment of quality of life of head and neck cancer patients receiving radical radiotherapy. Qual Life Res 1999; 8: 73-78.
Finizia C, Hammerlid E, Westin T, Lindstrom J. Quality of life and voice in patients with laryngeal carcinoma. A posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope 1998; 108: 1566-1573.
National Cancer Registry Programme, Biennial Report, 1988–89: An epidemiological study. Indian Council of Medical Research, New Delhi, 1992.
Consensus Conference. Oral complications of cancer therapies: Diagnosis, prevention and treatment. National Institutes of Health Conn Med 1989; 53: 595-601.
Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N. Stevenson-Moore D. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999; 21: 1-11.
Ringash J, Redelmeier DA, O'Sullivan B, Bezjak A. Quality of life and utility in irradiated laryngeal cancer patients. Int J Radiat Oncol Biol Phys 2000; 47: 875-881.
Schwartz S, Patrick DL, Yueh B. Quality of life outcomes in the evaluation of head and neck cancer treatments. Arch Otolaryngol HN Surg 2001; 127: 673-678.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organisation for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH. Late effects of normal tissues. Consensus conference. Int J Radiat Oncol Biol Phys 1995; 31: 1035-1365.
Aaronson NK, Ahmedzai S, Bergman B, et al. EORTC QLQ-C30. A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
Bjordal K, Kaasa S. Psychometric validation of the EORTC core QOL Questionnaire, 30-item version and a diagnosis specific module for head and neck cancer patient. Acta Oncol 1992; 31: 311-321.
Kaasa S, Bjordal K, Aaronson NK, et al. The EORTC core QOL questionnaire (QLQ-C30). Validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995; 31(A): 2260-2263.
Fayers P, Aaronson NK, Bjordal K, Sullivan M. EORTC QLQ-C30 Scoring Manual. Belgium: EORTC Data Center, 1995.
List MA, Stracks J. Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. Curr Opin Oncol 2000; 12: 215-220.
Jansma J, Vissink A, Spijkervert FKL, et al. Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 1992; 70: 2171-2180.
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of life questionnaire-H&N 35. J Clin Oncol 1999; 17: 1008-1019.
Epstein JB, Robertson M, Emerton S, Philips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001; 23: 389-398.